Tiziana Life Sciences Ltd
TLSA
$0.81
$0.00991.24%
NASDAQ
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.00% | -11.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -29.97% | |||
| Operating Income | 0.00% | 29.97% | |||
| Income Before Tax | 0.00% | 7.48% | |||
| Income Tax Expenses | 0.00% | -840.76% | |||
| Earnings from Continuing Operations | 0.00% | 48.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 48.71% | |||
| EBIT | 0.00% | 29.97% | |||
| EBITDA | 0.00% | 30.04% | |||
| EPS Basic | 0.00% | 48.87% | |||
| Normalized Basic EPS | 0.00% | 21.77% | |||
| EPS Diluted | 0.00% | 48.87% | |||
| Normalized Diluted EPS | 0.00% | 21.77% | |||
| Average Basic Shares Outstanding | 0.00% | 0.42% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||